Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of New Postoperative Intraretinal Cystoid Changes With Respect to Postsurgical Treatment Strategies After Vitrectomy With Membrane Peeling Due to Epiretinal Membranes

NCT06948851 is registered in ClinicalTrials.gov with Prim. Prof. Dr. Oliver Findl, MBA as lead sponsor.

NCT NCT06948851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06948851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of New Postoperative Intraretinal Cystoid Changes With Respect to Postsurgical Treatment Strategies After Vitrectomy With Membrane Peeling Due to Epiretinal Membranes
Lead sponsor
Prim. Prof. Dr. Oliver Findl, MBA
Phase
Observational
Overall status
Active, not recruiting
Start date
May 16, 2024
Completion date
April 30, 2025
Enrollment
114 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epiretinal membrane